# A Rare Clinical Presentation of Malignant Pleural Mesothelioma With Central Nervous System Metastases: A Case Report

**Authors:** Magdalena A Miernik-Skrzypczak, Elwira Misztela-Lisiecka, Piotr Nowakowski, Anna Strozak, Grazyna Waska

PMC · DOI: 10.7759/cureus.92297 · 2025-09-14

## TL;DR

A 63-year-old woman with malignant pleural mesothelioma developed rare central nervous system metastases, showing the aggressive and challenging nature of the disease.

## Contribution

This case report presents an unusual clinical presentation of MPM with CNS metastases in a female patient.

## Key findings

- The patient showed a partial response to cisplatin and pemetrexed chemotherapy.
- CNS metastases were detected months after treatment completion.
- Palliative radiotherapy provided only temporary control of neurological symptoms.

## Abstract

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer arising from the pleural mesothelial cells, most often associated with long-term asbestos exposure. Symptoms are typically nonspecific, including shortness of breath, chest pain, and pleural effusion, which may delay diagnosis. We report a case of a 63-year-old woman with bilateral MPM and subsequent central nervous system (CNS) metastases. She received systemic chemotherapy with cisplatin and pemetrexed, achieving a partial radiological response. Several months after completing treatment, she developed neurological symptoms. Imaging revealed multiple CNS metastases. Palliative radiotherapy provided temporary control; however, her condition progressively deteriorated. This case illustrates an unusual presentation and metastatic pattern of MPM in a female patient, highlighting diagnostic and therapeutic challenges, as well as the aggressive nature of the disease despite palliative care.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), pemetrexed (PubChem CID 135410875)
- **Diseases:** malignant pleural mesothelioma (MONDO:0005112)

## Full-text entities

- **Diseases:** pleural effusion (MESH:D010996), shortness of breath (MESH:D004417), neurological symptoms (MESH:D009461), System (MESH:D015619), Metastases (MESH:D009362), cancer (MESH:D009369), MPM (MESH:D000086002), chest pain (MESH:D002637)
- **Chemicals:** asbestos (MESH:D001194), pemetrexed (MESH:D000068437), cisplatin (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12522516